W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Monitoring issues related to S. 2360, H.R. 4679: Stop Corporate Inversions Act of 2014 in the context of corporate acquisition activity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Education about access to therapies for children at risk of developing RSV(Respiratory Syncytial Virus), specifically with respect to guidelines by the American Academy of Pediatrics (AAP). Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.